Summary
Diabetes drug is first on Glaxo list
DIABETES drug Avandia will be the first GlaxoSmithKline drug to be listed on its clinical data register after New York state attorney general Eliot Spitzer's edict ordering greater disclosure. Trial findings will be open to public scrutiny on a GSK website.See the full content of this document
Extract
News in Brief
The UK pharmaceuticals giant also revealed that it is buying blood-thinning drugs Fraxiparine, Fraxo...
See the full content of this document
Sponsored links
